Chimeric Therapeutics Limited Appendix 4E Preliminary Final Report 1. Company details Name of entity: Chimeric Therapeutics Limited ABN: 68 638 835 828 Reporting period: For the year ended 30 June 2026 Previous period: For the year ended 30 June 2025 2. Results for announcement to...